Nicholson Garry A

CIK 00016408617 companiesBRISBANE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001640861

Recent Transactions

50 trades

Disposition to Issuer
Day One Biopharmaceuticals, Inc.$DAWN
Stock Option (right to buy Common Stock)
2025-11-06−32,335→ 0 total
Disposition to Issuer
Day One Biopharmaceuticals, Inc.$DAWN
Stock Option (right to buy Common Stock)
2025-11-06−33,900→ 0 total
Award
Day One Biopharmaceuticals, Inc.$DAWN
Stock Option (right to buy Common Stock)
2025-11-06+33,900→ 33,900 total
Disposition to Issuer
Day One Biopharmaceuticals, Inc.$DAWN
Stock Option (right to buy Common Stock)
2025-11-06−37,500→ 0 total
Award
Day One Biopharmaceuticals, Inc.$DAWN
Stock Option (right to buy Common Stock)
2025-11-06+37,500→ 37,500 total
Award
Day One Biopharmaceuticals, Inc.$DAWN
Stock Option (right to buy Common Stock)
2025-11-06+32,335→ 32,335 total
Award
TScan Therapeutics, Inc.$TCRX
Stock Option (Right to Buy)
2025-06-30+67,000→ 67,000 total
Award
Day One Biopharmaceuticals, Inc.$DAWN
Stock Option (right to buy Common Stock)
2025-06-02+22,500→ 22,500 total
Award
Day One Biopharmaceuticals, Inc.$DAWN
Deferred Restricted Stock Unit (RSU)
2025-06-02+15,000→ 15,000 total
Disposition from Tender
G1 Therapeutics, Inc.
Common Stock
2024-09-18−14,389→ 0 total
Disposition to Issuer
G1 Therapeutics, Inc.
Stock Option (right to buy)
2024-09-18−30,000→ 0 total
Disposition to Issuer
G1 Therapeutics, Inc.
Stock Option (right to buy)
2024-09-18−30,000→ 0 total
Disposition to Issuer
G1 Therapeutics, Inc.
Common Stock
2024-09-18−20,000→ 14,389 total
Disposition to Issuer
G1 Therapeutics, Inc.
Stock Option (right to buy)
2024-09-18−30,000→ 0 total
Award
G1 Therapeutics, Inc.
Common Stock
2024-06-13+10,000→ 34,389 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2024-06-13+30,000→ 30,000 total
Award
TScan Therapeutics, Inc.$TCRX
Stock Option (Right to Buy)
2024-06-12+47,500→ 47,500 total
Award
TScan Therapeutics, Inc.$TCRX
Stock Option (Right to Buy)
2024-06-12+23,750→ 23,750 total
Award
Day One Biopharmaceuticals, Inc.$DAWN
Stock Option (right to buy Common Stock)
2024-05-23+32,335→ 32,335 total
Award
Day One Biopharmaceuticals, Inc.$DAWN
Director Stock Option (Right to buy Common Stock)
2023-06-22+37,500→ 37,500 total
Award
NextCure, Inc.$NXTC
Stock Option (Right to Buy)
2023-06-22+14,250→ 14,250 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2023-06-15+30,000→ 30,000 total
Award
G1 Therapeutics, Inc.
Common Stock
2023-06-15+10,000→ 24,389 total
Award
Day One Biopharmaceuticals, Inc.$DAWN
Stock Option (Right to buy Common Stock)
2022-09-12+33,900→ 33,900 total
Disposition to Issuer
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2022-08-17−23,400→ 0 total
Disposition to Issuer
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2022-08-17−8,500→ 0 total
Award
NextCure, Inc.$NXTC
Stock Option (Right to Buy)
2022-06-23+14,250→ 14,250 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2022-06-23+30,000→ 30,000 total
Award
G1 Therapeutics, Inc.
Common Stock
2022-06-23+10,000→ 14,389 total
Award
NextCure, Inc.$NXTC
Stock Option (Right to Buy)
2021-06-24+14,250→ 14,250 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2021-06-17+19,620→ 19,620 total
Award
G1 Therapeutics, Inc.
Common Stock
2021-06-17+4,389→ 4,389 total
Award
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2021-06-02+8,500→ 8,500 total
Disposition to Issuer
FIVE PRIME THERAPEUTICS, INC.
Stock Option (right to buy)
2021-04-16−10,000→ 0 total
Disposition to Issuer
FIVE PRIME THERAPEUTICS, INC.
Stock Option (right to buy)
2021-04-16−20,000→ 0 total
Disposition to Issuer
FIVE PRIME THERAPEUTICS, INC.
Stock Option (right to buy)
2021-04-16−15,000→ 0 total
Disposition to Issuer
FIVE PRIME THERAPEUTICS, INC.
Stock Option (right to buy)
2021-04-16−15,000→ 0 total
Award
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2020-06-15+23,400→ 23,400 total
Disposition to Issuer
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2020-06-15−25,000→ 0 total
Award
NextCure, Inc.$NXTC
Stock Option (Right to Buy)
2020-06-11+28,500→ 28,500 total
Award
G1 Therapeutics, Inc.
Stock Option (right to buy)
2020-06-11+20,000→ 20,000 total
Award
NextCure, Inc.$NXTC
Stock Option (Right to Buy)
2020-06-11+16,083→ 16,083 total
Award
FIVE PRIME THERAPEUTICS, INC.
Stock Option (right to buy)
2020-05-14+20,000→ 20,000 total
Award
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2020-01-22+25,000→ 25,000 total
Award
G1 Therapeutics, Inc.
Stock Option (right to buy)
2019-06-12+100,000→ 100,000 total
Award
G1 Therapeutics, Inc.
Stock Option (right to buy)
2019-06-12+20,000→ 20,000 total
Award
FIVE PRIME THERAPEUTICS, INC.
Stock Option (right to buy)
2019-06-10+15,000→ 15,000 total
Disposition to Issuer
TESARO, Inc.
Director Nonqualified Stock Option (right to buy)
2019-01-22−12,000→ 0 total
Disposition from Tender
TESARO, Inc.
Common Stock
2019-01-22$75.00/sh−1,671→ 0 total
Disposition to Issuer
TESARO, Inc.
Director Nonqualified Stock Option (right to buy)
2019-01-22−12,000→ 0 total

Companies

Recent Filings

Address

1800 SIERRA POINT PARKWAY, SUITE 200

BRISBANE, CA, 94005

View on SEC.gov